Regeneron Pharmaceuticals | Vermögenswerte



Assets Veränderung Datum
AbbVie USD 135.16B 8.26B 2024-12
Agios Pharmaceuticals USD 1.66B 128.6M 2024-12
Alnylam Pharmaceuticals USD 4.24B 34.94M 2024-12
Amgen USD 91.84B 956M 2024-12
Astellas Pharma JPY 3.45T 10.61B 2024-12
AstraZeneca USD 104.04B 887M 2024-12
Biogen USD 28.05B 263.9M 2024-12
BioMarin Pharmaceutical USD 6.99B 137.74M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
Gilead Sciences USD 59B 4.47B 2024-12
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
Incyte USD 5.44B 431.89M 2024-12
Ionis Pharmaceuticals USD 3B 77.42M 2024-12
J&J USD 180.1B 1.82B 2024-12
Kyowa Hakko Kirin JPY 1.07T 25.4B 2024-12
Merck USD 117.11B 426M 2024-12
Moderna USD 14.14B 1.66B 2024-12
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Regeneron Pharmaceuticals USD 37.76B 317.5M 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 132.8B 3.04B 2024-12
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
Teva Pharmaceutical Industries USD 39.33B 2.43B 2024-12
Ultragenyx Pharmaceutical USD 1.5B 34.91M 2024-12
United Therapeutics USD 7.36B 240.9M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Regeneron Pharmaceuticals Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.